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Background. Urinary tract infection (UTI) is common among patients at
Veterans Affairs Medical Centers (VAMCs), many of whom are elderly men with underlying medical or urological problems. Most UTI treatment guidelines address uncomplicated UTI in women and presume knowledge of local antimicrobial susceptibility testing (AST) patterns for uropathogens, which often are unknown or are inferred from E. coli. To inform selection of empiric therapy for UTI at our VAMC, we compiled AST data for one year's urine isolates.
Methods. We compiled AST results (bioMerieux VITEK®) for the 2,494 significant urine isolates from the Minneapolis VAMC clinical microbiology laboratory from June 2013 through May 2014. For "drug-bug" combinations that were not tested we imputed results based on local or published data, and/or expert opinion. We then calculated cumulative % susceptible for 25 relevant antimicrobial agents, overall and stratified by Gram stain group and clinical site (intensive care unit, inpatient, outpatient, community residential centers, or extended care). In ambiguous situations susceptibility was analyzed as both 0% and 100%.
Results. The 2,494 urine isolates included 946 Gram-positive and 1,548 Gramnegative organisms. Species distribution varied significantly by clinical site. E. coli represented only 27% of isolates overall (9-37%, depending on site). Enterococcus (14%) and other Gram-positives (23%) were also prevalent. Cumulative AST profiles varied significantly (i) by Gram stain group, (ii) between E. coli and other Gram-negatives, and (iii) by clinical site. No tested oral agent provided ≥ 80% overall susceptibility. Although AST data were unavailable for fosfomycin, imputation suggested 82%-95% susceptibility overall.
Conclusion. Among urine isolates from veterans, E. coli was a minor contributor and a poor surrogate for total population AST profiles. The only oral agent that provided ≥ 80% susceptibility overall was fosfomycin, suggesting that it could be an important option for empiric lower UTI therapy for veterans. Urine isolate-specific antibiograms that reflect local AST data, stratified by Gram stain group and clinical site, could improve empirical UTI therapy for veterans, as could performance of urine Gram stains. Friday, October 6, 2017: 12:30 PM Background. Urinary tract infections (UTIs) are the most common bacterial infection among adults in the community. Recent data suggest an increase in bacterial resistance to first line antibiotics used for UTI, though the impact on clinical outcomes is unclear. The objective of our study was to determine clinical outcomes associated with community-onset extended-spectrum cephalosporin-resistant (ESC-R) Enterobacteriaceae (EB) UTI.
Methods. A retrospective cohort study was conducted in a large health system from 2010 to 2013. All patients presenting to an emergency department or outpatient clinic with UTI due to EB were included. Exposed subjects were those with an EB demonstrating resistance to an ESC (ceftriaxone or ceftazidime). Unexposed subjects were those with ESC-susceptible EB UTIs and were matched to cases 1:1 based on study year. Multivariable logistic regression analyses were performed to evaluate the association between ESC-R EB UTI and 1) clinical failure (defined as ongoing symptoms, repeat positive culture, or need for additional antibiotics within 7 days); 2) inappropriate initial antibiotic therapy (IIAT) (defined as failure to receive an antibiotic to which the organism was susceptible within 48 hours of presentation).
Results. A total of 302 patients with community-onset EB UTI were included. On multivariable analyses, a UTI with an ESC-R EB was significantly associated with clinical failure (odds ratio [OR] 5.12, 95% confidence interval [CI] 2.79-9.39, P < 0.01). Other variables independently associated with clinical failure included presence of pyelonephritis at the time of UTI diagnosis (OR 2.15, 95% CI 1.14-4.03, p 0.02) and infection with Citrobacter species (OR 29.56, , P < 0.01). ESC-R EB UTI was also associated with IIAT on multivariable analysis (OR 3.73, 95% CI 2.25-6.21, P < 0.01).
Conclusion. Community-onset UTI due to an ESC-R EB organism is associated with a significantly increased risk of clinical failure, which may be due in part to the use of inappropriate initial antibiotic therapy. Further studies are needed to determine which patients in the community are at high risk for drug-resistant infection to help inform prompt urine culture ordering and appropriate antibiotic prescribing for ESC-R EB.
Disclosures. All authors: No reported disclosures. Background. Recurrent UTI is a common complication of chronic urinary catheter use. We report our experience with the use of antibiotic bladder irrigation to reduce catheter associated UTI and systemic antibiotics use.
Antibiotic Bladder Irrigation in Preventing and
Methods. Retrospective chart review of patients treated with antibiotic bladder irrigation for recurrent UTI related to chronic urinary catheter (2013) (2014) (2015) (2016) . Data collected include demographic, co-morbidities, urological anomalies, symptoms, documented pathogens during episodes of infection, and irrigation medication used. Antibiotic regimen included: gentamicin, gentamicin alternated with piperacillin-tazobactam, or tobramycin once weekly. Parameters for successful therapy and alleviation of symptoms included complete relief of symptoms for six months and no systemic antibiotics use for six months post initiation of therapy, or reduced frequency of infections for one year post initiation of therapy.
Results. 39 patients were enrolled, all were patients who had been referred to infectious disease physicians after persistence of symptoms despite multiple rounds of systemic antibiotics and had at least 6 episode of documented UTI despite following guideline for aseptic urinary catheter insertion and care. Mean age 66.5 y (range 27-92), 69% male. Most common urologic problem was neurogenic bladder in 48% and prostate or bladder surgery. 5 self-catheterize, 12 had suprapubic catheter and 22 had chronic indwelling catheter. Most common co-morbidities include: DM, BPH, paraplegia, spina bifida and multiple sclerosis. Most common presenting symptoms were abdominal pain 49% and fever 34%. Most common organisms were Escherichia coli 38%, Pseudomonas aeruginosa 23% and Enterococcus faecalis 18%. 67% used gentamicin bladder irrigation. 26 (66.67%) met the criteria for alleviation of symptoms and success with antibiotic irrigation therapy, and a further four featured improvement of frequency of symptoms despite not successfully meeting the study's pre-set criteria for full improvement. Patient did not report any associated side effect.
Conclusion. Use of antibiotic bladder irrigation was successful in reducing symptom frequency and requirement of systemic antibiotics. Further Studies needed to assess the benefit of this mode of therapy.
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